Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules

Virology

Volumn 435, Issue 2, 2013, Pages 472-484

  Pager, Cara T ^a   Schütz, Sylvia ^a   Abraham, Teresa M ^a   Luo, Guangxiang ^b   Sarnow, Peter ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Hepatitis C virus; Lipid droplets; Processing bodies; Stress granules; Viral RNA assembly

Indexed keywords

CELL PROTEIN; CORE PROTEIN; VIRUS RNA;

ARTICLE; CELL COMPONENT; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; PROCESSING BODY; PROTEIN LOCALIZATION; RNA STRUCTURE; STRESS GRANULE; VIRION; VIRUS INFECTIVITY; VIRUS RELEASE;

CELL LINE, TUMOR; CYTOPLASMIC GRANULES; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATOCYTES; HUMANS; RNA, VIRAL; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS RELEASE;

HEPATITIS C VIRUS;

EID: 84871702135     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.10.027     Document Type: Article

References (66)

1. Adler J., Parmryd I. Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A 2010, 77:733-742.
2. Anderson P., Kedersha N. RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 2009, 10:430-436.
3. Anderson P., Kedersha N. Stress granules. Curr. Biol. 2009, 19:R397-398.
4. Ariumi Y., Kuroki M., Kushima Y., Osugi K., Hijikata M., Maki M., Ikeda M., Kato N. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J. Virol. 2012, 85:6882-6892.
5. Arnaud N., Dabo S., Maillard P., Budkowska A., Kalliampakou K.I., Mavromara P., Garcin D., Hugon J., Gatignol A., Akazawa D., Wakita T., Meurs E.F. Hepatitis C virus controls interferon production through PKR activation. PLoS One 2010, 5:e10575.
6. Arribere J.A., Doudna J.A., Gilbert W.V. Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies. Mol. Cell. 2011, 44:745-758.
7. Backes P., Quinkert D., Reiss S., Binder M., Zayas M., Rescher U., Gerke V., Bartenschlager R., Lohmann V. Role of annexin A2 in the production of infectious hepatitis C virus particles. J. Virol. 2010, 84:5775-5789.
8. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M.J., Miyamura T., Brechot C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1200-1205.
9. Bartenschlager R., Penin F., Lohmann V., Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 2011, 19:95-103.
10. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
11. Bolte S., Cordelieres F.P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006, 224:213-232.
12. Brengues M., Teixeira D., Parker R. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 2005, 310:486-489.
13. Buchan J.R., Muhlrad D., Parker R. P bodies promote stress granule assembly in Saccharomyces cerevisiae. J. Cell. Biol. 2008, 183:441-455.
14. Buchan J.R., Nissan T., Parker R. Analyzing P-bodies and stress granules in Saccharomyces cerevisiae. Methods Enzymol. 2010, 470:619-640.
15. Buchan J.R., Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell. 2009, 36:932-941.
16. Chatel-Chaix L., Melancon P., Racine M.E., Baril M., Lamarre D. Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production. J. Virol. 2011, 85:11022-11037.
17. Cohen M., Stutz F., Belgareh N., Haguenauer-Tsapis R., Dargemont C. Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23. Nat. Cell. Biol. 2003, 5:661-667.
18. Cohen M., Stutz F., Dargemont C. Deubiquitination, a new player in Golgi to endoplasmic reticulum retrograde transport. J. Biol. Chem. 2003, 278:51989-51992.
19. Cougot N., Babajko S., Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 2004, 165:31-40.
20. Dougherty J.D., White J.P., Lloyd R.E. Poliovirus-mediated disruption of cytoplasmic processing bodies. J. Virol. 2011, 85:64-75.
21. Emara M.M., Brinton M.A. Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9041-9046.
22. Fenger-Gron M., Fillman C., Norrild B., Lykke-Andersen J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell. 2005, 20:905-915.
23. Fujimoto Y., Itabe H., Sakai J., Makita M., Noda J., Mori M., Higashi Y., Kojima S., Takano T. Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7. Biochim. Biophys. Acta 2004, 1644:47-59.
24. Garaigorta U., Chisari F.V. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 2009, 6:513-522.
25. Harris D., Zhang Z., Chaubey B., Pandey V.N. Identification of cellular factors associated with the 3'-nontranslated region of the hepatitis C virus genome. Mol. Cell. Proteomics 2006, 5:1006-1018.
26. Herker E., Harris C., Hernandez C., Carpentier A., Kaehlcke K., Rosenberg A.R., Farese R.V., Ott M. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat. Med. 2010, 16:1295-1298.
27. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 2002, 8:1489-1501.
28. Jangra R.K., Yi M., Lemon S.M. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J. Virol. 2010, 84:6810-6824.
29. Jopling C.L., Schutz S., Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4:77-85.
30. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
31. Kedersha N., Anderson P. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 2002, 30:963-969.
32. Kedersha N., Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol. 2007, 431:61-81.
33. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fritzler M.J., Scheuner D., Kaufman R.J., Golan D.E., Anderson P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell. Biol. 2005, 169:871-884.
34. Kedersha N.L., Gupta M., Li W., Miller I., Anderson P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell. Biol. 1999, 147:1431-1442.
35. Keum S.J., Park S.M., Jung J.H., Shin E.J., Jang S.K. The specific infectivity of hepatitis C virus changes through its life cycle. Virology 2012, 433:462-470.
36. Leung A.K., Calabrese J.M., Sharp P.A. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18125-18130.
37. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
38. Lindenbach B.D., Rice C.M. Flaviviridae: The Viruses and Their Replication 2001, Lippincott-Raven Publishers, Philadelphia, PA. 3 ed.
39. Liu J., Valencia-Sanchez M.A., Hannon G.J., Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 2005, 7:719-723.
40. Machlin E.S., Sarnow P., Sagan S.M. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3193-3198.
41. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 2007, 9:1089-1097.
42. Norman K.L., Sarnow P. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J. Virol. 2010, 84:666-670.
43. Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J., Chan E.K. Formation of GW bodies is a consequence of microRNA genesis. EMBO Rep. 2006, 7:904-910.
44. Perez-Vilaro G., Scheller N., Saludes V., Diez J. Hepatitis C virus infection alters p-body composition but is independent of p-body granules. J. Virol. 2012, 86:8740-8749.
45. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E., Filipowicz W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309:1573-1576.
46. Piotrowska J., Hansen S.J., Park N., Jamka K., Sarnow P., Gustin K.E. Stable formation of compositionally unique stress granules in virus-infected cells. J. Virol. 2010, 84:3654-3665.
47. Sato S., Fukasawa M., Yamakawa Y., Natsume T., Suzuki T., Shoji I., Aizaki H., Miyamura T., Nishijima M. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 2006, 139:921-930.
48. Scheller N., Mina L.B., Galao R.P., Chari A., Gimenez-Barcons M., Noueiry A., Fischer U., Meyerhans A., Diez J. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13517-13522.
49. Seeff L.B. The history of the "natural history" of hepatitis C (1968-2009). Liver Int. 2009, 29(Suppl. 1):89-99.
50. Sheth U., Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003, 300:805-808.
51. Sokoloski K.J., Dickson A.M., Chaskey E.L., Garneau N.L., Wilusz C.J., Wilusz J. Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe 2010, 8:196-207.
52. Solomon S., Xu Y., Wang B., David M.D., Schubert P., Kennedy D., Schrader J.W. Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol. Cell. Biol. 2007, 27:2324-2342.
53. Soncini C., Berdo I., Draetta G. Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease. Oncogene 2001, 20:3869-3879.
54. Spangberg K., Wiklund L., Schwartz S. HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3' ends of hepatitis C virus RNA of both polarities. Virology 2000, 274:378-390.
55. Tingting P., Caiyun F., Zhigang Y., Pengyuan Y., Zhenghong Y. Subproteomic analysis of the cellular proteins associated with the 3' untranslated region of the hepatitis C virus genome in human liver cells. Biochem. Biophys. Res. Commun. 2006, 347:683-691.
56. Tourriere H., Chebli K., Zekri L., Courselaud B., Blanchard J.M., Bertrand E., Tazi J. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J. Cell. Biol. 2003, 160:823-831.
57. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., Seraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 2002, 21:6915-6924.
58. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.-G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-796.
59. Ward A.M., Bidet K., Yinglin A., Ler S.G., Hogue K., Blackstock W., Gunaratne J., Garcia-Blanco M.A. Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures. RNA Biol. 2011, 8.
60. Wehner K.A., Schutz S., Sarnow P. OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress. Mol. Cell. Biol. 2010, 30:2006-2016.
61. White J.P., Cardenas A.M., Marissen W.E., Lloyd R.E. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2007, 2:295-305.
62. Yi Z., Fang C., Pan T., Wang J., Yang P., Yuan Z. Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component. Biochem. Biophys. Res. Commun. 2006, 350:174-178.
63. Yi Z., Pan T., Wu X., Song W., Wang S., Xu Y., Rice C.M., Macdonald M.R., Yuan Z. Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication. J. Virol. 2011, 85:6996-7004.
64. Yu J.H., Yang W.H., Gulick T., Bloch K.D., Bloch D.B. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 2005, 11:1795-1802.
65. Yu S.F., Lujan P., Jackson D.L., Emerman M., Linial M.L. The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome. PLoS Pathog. 2011, 7:e1002303.
66. Yuan J., Luo K., Zhang L., Cheville J.C., Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 2010, 140:384-396.